Loading chat...
AR HB1801
Bill
Status
4/21/2025
Primary Sponsor
Kendra Moore
Click for details
AI Summary
-
FDA-registered 503B outsourcing facilities with Arkansas State Board of Pharmacy permits may sell compounded legend drugs and controlled substances to Arkansas-licensed retail pharmacies, healthcare facilities, and healthcare providers (physicians, nurse practitioners) for patient dispensing or administration
-
Sales are prohibited to wholesale distributors, pharmaceutical repackagers, relabelers, marketing firms, or any other entities not specifically authorized
-
Outsourcing facilities must comply with Current Good Manufacturing Practices regulations under 21 C.F.R. Parts 210, 211, and 212 as existing on January 1, 2025
-
The Arkansas State Board of Pharmacy must adopt rules for retail pharmacies dispensing compounds from outsourcing facilities, including patient education requirements and disclosure of the outsourcing facility name
-
Approved April 21, 2025, as Act 961 of the Regular Session
Legislative Description
To Authorize An Outsourcing Facility Of Legend Drugs And Controlled Substances That Compounds A Product To Sell The Compounded Product To Certain Entities.
Last Action
Notification that HB1801 is now Act 961
4/21/2025